Work

Good Research Practices for Measuring Drug Costs in Cost Effectiveness Analyses: Issues and Recommendations: The ISPOR Drug Cost Task Force Report—Part I

Year: 2009

Type: article

Source: Value in Health

DOI: 10.1111/j.1524-4733.2009.00663.x

Authors: Joel W. Hay, Jim Smeeding, Norman V. Carroll, Michael Drummond, Louis P. Garrison, Edward C. Mansley, C. Daniel Mullins, Jack M. Mycka, Brian Seal, Lizheng Shi

Institutions: University of Southern California, Virginia Commonwealth University, University of York, University of Washington, Merck & Co., Inc., Rahway, NJ, USA (United States), University of Maryland, Baltimore, Sanofi (United States), Tulane University

Language: English

Topic: Health Systems, Economic Evaluations, Quality of Life

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2164051725

FWCI: 9.608

Cites: 20

Cited by: 107

Related to: 10